Cargando…
Dosimetry during adjuvant (131)I therapy in patients with differentiated thyroid cancer-clinical implications
The activity of radioiodine ((131)I) used in adjuvant therapy for thyroid cancer ranges between 30 mCi (1.1 GBq) and 150 mCi (5.5 GBq). Dosimetry based on Marinelli's formula, taking into consideration the absorbed dose in the postoperative tumour bed (D) should systematise the determination of...
Autores principales: | Szumowski, Piotr, Abdelrazek, Saeid, Iwanicka, Dorota, Mojsak, Małgorzata, Sykała, Monika, Żukowski, Łukasz, Siewko, Katarzyna, Adamska, Agnieszka, Maliszewska, Katarzyna, Popławska-Kita, Anna, Szelachowska, Małgorzata, Krętowski, Adam, Myśliwiec, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260769/ https://www.ncbi.nlm.nih.gov/pubmed/34230618 http://dx.doi.org/10.1038/s41598-021-93431-1 |
Ejemplares similares
-
Enhancing the efficacy of (131)I therapy in non-toxic multinodular goitre with appropriate use of methimazole: an analysis of randomized controlled study
por: Szumowski, Piotr, et al.
Publicado: (2019) -
Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
por: Szumowski, Piotr, et al.
Publicado: (2019) -
Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
por: Sykała, Monika, et al.
Publicado: (2021) -
Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer
por: Buczyńska, Angelika, et al.
Publicado: (2023) -
Calculation of therapeutic activity of radioiodine in
Graves’ disease by means of Marinelli’s formula, using technetium
((99m)Tc) scintigraphy
por: Szumowski, Piotr, et al.
Publicado: (2016)